TEVA $TEVA AND TRUMP ADMINISTRATION ANNOUNCE INTENT TO REACH DRUG-PRICING DEAL
The company says it remains in active discussions with the administration on an agreement anchored in all four of the president's drug pricing priorities, covering affordable medicines and US supply chain security. Conditions of the negotiation remain confidential, per the company.